United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...

United Therapeutics UTHR has outperformed the market over the past 20 years by 6.47% on an annualized basis producing an average annual return of 14.94%. Currently, United Therapeutics has a ...

Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the ...